News BMS’ Opdivo Plus Cisplatin and Gemcitabine Gain EC’s Approval for Treating Urothelial Carcinoma ByDipanshu DixitMay 29, 20240Comments
News Tris Pharma’s Onyda XR Gains the US FDA’s Approval for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) ByDipanshu DixitMay 29, 20240Comments
INSIGHTS+ Know Your Investor (May Edition): Alexandria Venture InvestmentByPrince GiriMay 28, 20240Comments
THOUGHTSPOT The Future of Dental Healthcare: Personalized Treatment and Care ByOwen PatelMay 28, 20240Comments
VIEWPOINTS Funds Raised: Jason Hannon from Mainstay Medical in a Stimulating Conversation with PharmaShotsBySaurabh ChaubeyMay 27, 20240Comments
News Fresenius Reports the US FDA’s BLA Acceptance of FKS518 (Biosimilar, Denosumab) ByDipanshu DixitMay 27, 20240Comments
THOUGHTSPOT HCC 101: A Comprehensive Overview for Primary Care PhysiciansByEmma MonroeMay 24, 20240Comments
THOUGHTSPOT Menopause Care: How Personalized Medicine Helps You Cope Better (But Challenges Remain)ByAndrea LaceyMay 23, 20240Comments
